002326.SZ
Zhejiang Yongtai Technology Co.,Ltd. [002326.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002326.SZ Stock Summary
Top 10 Correlated Stocks
002326.SZ
In the News
002326.SZ Financial details
Company Rating
Neutral
Market Cap
8.39B
Income
-91.68M
Revenue
4.57B
Book val./share
4.23
Cash/share
1.55
Dividend
0.1
Dividend %
0.87%
Employees
3.89K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
-109.72
Forward P/E
-
PEG
8.22
P/S
2.3
P/B
2.71
P/C
5.94
P/FCF
-25.83
Quick Ratio
0.54
Current Ratio
0.84
Debt / Equity
1.15
LT Debt / Equity
0.42
-
-
EPS (TTM)
-0.11
EPS next Y
-
EPS next Q
-
EPS this Y
96.88%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.73%
Revenue last 5Y
13.97%
Revenue Q/Q
1.07%
EPS Q/Q
-1152.63%
-
-
-
-
SMA20
-9.09%
SMA50
-9.09%
SMA100
-23.08%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-3%
ROC
-0.02%
Gross Margin
19%
Oper. Margin
-3%
Profit Margin
-2%
Payout
-285%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.93-21.55
52W High
-56.14%
52W Low
+31.57%
RSI
41
Rel Volume
0.71
Avg Volume
19.18M
Volume
13.63M
Perf Week
-16.5%
Perf Month
-9.17%
Perf Quarter
-26.96%
Perf Half Y
-28.33%
-
-
-
-
Beta
0.809
-
-
Volatility
0.6%, 0.52%
Prev Close
-2.33%
Price
9.21
Change
3.48%
002326.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.73 | 3.91 | 3.94 | 5.1 | 7.23 | |
| Net income per share | 0.5 | 0.31 | 0.09 | 0.32 | 0.63 | |
| Operating cash flow per share | 0.81 | 0.44 | 0.39 | 0.66 | 0.26 | |
| Free cash flow per share | 0.33 | -0.01 | -0.9 | -0.24 | -0.59 | |
| Cash per share | 0.98 | 1.05 | 0.83 | 0.89 | 1.12 | |
| Book value per share | 3.41 | 3.65 | 3.82 | 4.02 | 3.91 | |
| Tangible book value per share | 2.02 | 2.33 | 2.55 | 2.92 | 2.97 | |
| Share holders equity per share | 3.41 | 3.65 | 3.82 | 4.02 | 3.91 | |
| Interest debt per share | 2.49 | 2.41 | 2.97 | 3.5 | 4.24 | |
| Market cap | 5.38B | 8.68B | 9.66B | 44.89B | 19.14B | |
| Enterprise value | 6.96B | 9.97B | 11.61B | 47.16B | 21.76B | |
| P/E ratio | 12.19 | 31.94 | 124.33 | 160.15 | 34.54 | |
| Price to sales ratio | 1.63 | 2.53 | 2.8 | 10.05 | 3.02 | |
| POCF ratio | 7.48 | 22.71 | 27.99 | 77.93 | 85.55 | |
| PFCF ratio | 18.43 | -698.67 | -12.28 | -212.97 | -37.12 | |
| P/B Ratio | 1.79 | 2.71 | 2.89 | 12.74 | 5.58 | |
| PTB ratio | 1.79 | 2.71 | 2.89 | 12.74 | 5.58 | |
| EV to sales | 2.11 | 2.91 | 3.36 | 10.55 | 3.43 | |
| Enterprise value over EBITDA | 8.54 | 15.4 | 18.97 | 42.56 | 15.71 | |
| EV to operating cash flow | 9.67 | 26.1 | 33.63 | 81.87 | 97.29 | |
| EV to free cash flow | 23.82 | -802.92 | -14.76 | -223.74 | -42.22 | |
| Earnings yield | 0.08 | 0.03 | 0.01 | 0.01 | 0.03 | |
| Free cash flow yield | 0.05 | 0 | -0.08 | 0 | -0.03 | |
| Debt to equity | 0.7 | 0.63 | 0.75 | 0.83 | 1.05 | |
| Debt to assets | 0.32 | 0.29 | 0.32 | 0.3 | 0.32 | |
| Net debt to EBITDA | 1.93 | 2 | 3.19 | 2.05 | 1.9 | |
| Current ratio | 0.84 | 0.89 | 0.87 | 0.75 | 0.77 | |
| Interest coverage | 5.64 | 3.21 | 3.41 | 6.39 | 6.36 | |
| Income quality | 1.67 | 1.47 | 4.44 | 1.73 | 0.34 | |
| Dividend Yield | 0.03 | 0.03 | 0.01 | 0 | 0.01 | |
| Payout ratio | 0.4 | 0.88 | 1.3 | 0.52 | 0.38 | |
| Sales general and administrative to revenue | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.21 | 0.19 | 0.16 | 0.12 | 0.1 | |
| Capex to operating cash flow | -0.59 | -1.03 | -3.28 | -1.37 | -3.3 | |
| Capex to revenue | -0.13 | -0.12 | -0.33 | -0.18 | -0.12 | |
| Capex to depreciation | -2.22 | -1.75 | -4.38 | -2.74 | -2.04 | |
| Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | 0 | |
| Graham number | 6.19 | 5.04 | 2.76 | 5.38 | 7.46 | |
| ROIC | 0.08 | 0.05 | 0.05 | 0.1 | 0.1 | |
| Return on tangible assets | 0.08 | 0.05 | 0.01 | 0.03 | 0.05 | |
| Graham Net | -1.76 | -1.75 | -2.71 | -4.06 | -5.29 | |
| Working capital | -502.97M | -331.27M | -396.2M | -1.18B | -1.3B | |
| Tangible asset value | 1.79B | 2.04B | 2.23B | 2.56B | 2.61B | |
| Net current asset value | -901.26M | -832.25M | -1.55B | -2.4B | -3.14B | |
| Invested capital | 0.7 | 0.63 | 0.75 | 0.83 | 1.05 | |
| Average receivables | 955.07M | 952.76M | 972.06M | 1.21B | 1.47B | |
| Average payables | 730.02M | 884.32M | 1.08B | 1.46B | 1.85B | |
| Average inventory | 652.83M | 690.38M | 757.6M | 996.6M | 1.43B | |
| Days sales outstanding | 109.12 | 97.94 | 108.3 | 113.95 | 89.04 | |
| Days payables outstanding | 120.07 | 145.09 | 170.54 | 217.02 | 160.97 | |
| Days of inventory on hand | 99.25 | 107.84 | 114.01 | 149.56 | 135.82 | |
| Receivables turnover | 3.34 | 3.73 | 3.37 | 3.2 | 4.1 | |
| Payables turnover | 3.04 | 2.52 | 2.14 | 1.68 | 2.27 | |
| Inventory turnover | 3.68 | 3.38 | 3.2 | 2.44 | 2.69 | |
| ROE | 0.15 | 0.09 | 0.02 | 0.08 | 0.16 | |
| Capex per share | -0.48 | -0.45 | -1.29 | -0.9 | -0.84 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.81 | 1.66 | 1.15 | 1.19 | 1.21 | |
| Net income per share | 0.09 | 0.02 | 0.02 | 0.02 | -0.16 | |
| Operating cash flow per share | 0.09 | 0.02 | 0.02 | -0.4 | 0.16 | |
| Free cash flow per share | -0.43 | 0.36 | -0.57 | -0.11 | -0.15 | |
| Cash per share | 1.13 | 1.12 | 1.02 | 1.06 | 1.55 | |
| Book value per share | 4.62 | 3.91 | 3.94 | 3.85 | 4.23 | |
| Tangible book value per share | 3.62 | 2.97 | 2.96 | 2.85 | 3.2 | |
| Share holders equity per share | 4.62 | 3.91 | 3.94 | 3.85 | 4.23 | |
| Interest debt per share | 3.9 | 4.13 | 4.47 | 4.81 | 4.89 | |
| Market cap | 19.85B | 19.14B | 18.34B | 13.4B | 11.22B | |
| Enterprise value | 22.25B | 21.76B | 21.34B | 16.66B | 14.13B | |
| P/E ratio | 62.33 | 298.85 | 270.06 | 251 | -20.32 | |
| Price to sales ratio | 12.69 | 13.15 | 18.23 | 12.8 | 10.6 | |
| POCF ratio | 249.33 | 1.2K | 1.08K | -37.9 | 81.36 | |
| PFCF ratio | -53.56 | 59.86 | -36.75 | -136.48 | -86.75 | |
| P/B Ratio | 4.97 | 5.58 | 5.31 | 3.97 | 3.03 | |
| PTB ratio | 4.97 | 5.58 | 5.31 | 3.97 | 3.03 | |
| EV to sales | 14.22 | 14.96 | 21.21 | 15.91 | 13.35 | |
| Enterprise value over EBITDA | 126.91 | 255.26 | 391.96 | 2.81K | -98.65 | |
| EV to operating cash flow | 279.47 | 1.36K | 1.26K | -47.13 | 102.48 | |
| EV to free cash flow | -60.04 | 68.08 | -42.76 | -169.69 | -109.27 | |
| Earnings yield | 0 | 0 | 0 | 0 | -0.01 | |
| Free cash flow yield | -0.02 | 0.02 | -0.03 | -0.01 | -0.01 | |
| Debt to equity | 0.84 | 1.05 | 1.12 | 1.24 | 1.15 | |
| Debt to assets | 0.3 | 0.32 | 0.34 | 0.37 | 0.37 | |
| Net debt to EBITDA | 13.69 | 30.81 | 55.14 | 550.45 | -20.33 | |
| Current ratio | 0.73 | 0.77 | 0.8 | 0.82 | 0.84 | |
| Interest coverage | 4.94 | 1.28 | 1.13 | -0.93 | -4.39 | |
| Income quality | 1 | 1 | 1 | -26.49 | -1 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0.36 | 1.95 | 2.24 | 10.89 | -0.34 | |
| Sales general and administrative to revenue | 0.21 | -0.13 | 0.14 | -0.04 | 0.34 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | |
| Intangibles to total assets | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Capex to operating cash flow | -5.65 | 18.97 | -30.4 | -0.72 | -1.94 | |
| Capex to revenue | -0.29 | 0.21 | -0.51 | 0.24 | -0.25 | |
| Capex to depreciation | -4.63 | 3.12 | -5.14 | 2.54 | 1.37 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.09 | 1.27 | 1.31 | 1.15 | 3.87 | |
| ROIC | 0.02 | 0.02 | 0 | 0.24 | -0.02 | |
| Return on tangible assets | 0.01 | 0 | 0 | 0 | -0.01 | |
| Graham Net | -4.55 | -5.29 | -5.61 | -5.65 | -5.15 | |
| Working capital | -1.56B | -1.3B | -1.1B | -961.71M | -790.9M | |
| Tangible asset value | 3.13B | 2.61B | 2.6B | 2.5B | 2.81B | |
| Net current asset value | -2.59B | -3.14B | -3.46B | -3.47B | -3.3B | |
| Invested capital | 0.84 | 1.05 | 1.12 | 1.24 | 1.15 | |
| Average receivables | 1.76B | 1.61B | 1.6B | 1.52B | 1.39B | |
| Average payables | 2.15B | 2.05B | 1.88B | 1.71B | 1.56B | |
| Average inventory | 1.41B | 1.54B | 1.59B | 1.63B | 1.52B | |
| Days sales outstanding | 96.22 | 95.61 | 148.73 | 118.05 | 119.15 | |
| Days payables outstanding | 161.28 | 168.79 | 214.85 | 161.65 | 138.05 | |
| Days of inventory on hand | 107.51 | 142.42 | 181.9 | 173.46 | 120.38 | |
| Receivables turnover | 0.94 | 0.94 | 0.61 | 0.76 | 0.76 | |
| Payables turnover | 0.56 | 0.53 | 0.42 | 0.56 | 0.65 | |
| Inventory turnover | 0.84 | 0.63 | 0.49 | 0.52 | 0.75 | |
| ROE | 0.02 | 0 | 0 | 0 | -0.04 | |
| Capex per share | -0.52 | 0.35 | -0.59 | 0.29 | -0.3 |
002326.SZ Frequently Asked Questions
What is Zhejiang Yongtai Technology Co.,Ltd. stock symbol ?
Zhejiang Yongtai Technology Co.,Ltd. is a CN stock and trading under the symbol 002326.SZ
What is Zhejiang Yongtai Technology Co.,Ltd. stock quote today ?
Zhejiang Yongtai Technology Co.,Ltd. stock price is $9.21 today.
Is Zhejiang Yongtai Technology Co.,Ltd. stock public?
Yes, Zhejiang Yongtai Technology Co.,Ltd. is a publicly traded company.
Company Profile
- Volume Average 19.18M
- Market Capitalization 8.39B
- Employee 3.89K
- CEO Ms. Ying Mei Wang
- Headquarters Linhai,CN
- IPO Date 2009-12-22
-
Website
https://www.yongtaitech.com 
Zhejiang Yongtai Technology Co.,Ltd. engages in the research and development, manufacture, and sale of fluorinate chemicals in China. It offers fluorinated pharmaceutical compounds applied to drugs in fields, including anti-diabetic, anti-virus, cardiovascular, anti-bacterial quinolones, nervous system, etc.; and intermediates used in insecticides and fungicide. The company also provides liquid crystal material, lithium battery material, and other energy materials, as well as contract manufacturing service to pharmaceutical and chemical industry. Zhejiang Yongtai Technology Co.,Ltd. was founded in 1999 and is headquartered in Linhai, China.
